Opioid Use Disorder

The Congressional Academic Medicine Caucus and the Association of American Medical Colleges today sponsored a Capitol Hill briefing to highlight the urgent nationwide need for more physicians to treat substance use disorders.
The Centers for Medicare & Medicaid Services (CMS) Nov. 1 issued a final rule updating physician fee schedule (PFS) payments for calendar year (CY) 2020. The rule also includes several policies implementing year four of the quality payment program (QPP) created by the Medicare Access and CHIP…
In the AHA Stat Blog marking National Addiction Treatment Week, Raymond Waller, hospital administrator at Ascension Brighton Center for Recovery in Brighton, Mich., and 2020 chair of AHA’s Behavioral Health Council, urges readers to ask their members of Congress to cosponsor this AHA-supported…
The AHA and six other organizations comments to the Drug Enforcement Administration on its proposed rule regarding controlled substances quotas.
The AHA supports a number of proposed policy changes that ensure access to care, support public health efforts, improve quality and promote regulatory relief. Specifically, we strongly support CMS’s proposed reversal of its previously finalized policies for evaluation and management payments.
AHA's feedback on the Department of Health and Human Services’ Office of the Assistant Secretary for Planning and Evaluation’s request for information on ensuring patient access and effective drug enforcement regarding controlled substances.
On Oct. 24, 2018, President Trump signed into law the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act of 2018 (P.L. 115-271).
We were pleased to see the House of Representatives this week move forward dozens of bills designed to address aspects of the opioid epidemic that costs more than 100 American lives each day and continues to ravage communities across the nation.